Format

Send to

Choose Destination
See comment in PubMed Commons below
Eur J Pharmacol. 2000 Jan 28;388(2):R3-4.

LY354740 affects startle responding but not sensorimotor gating or discriminative effects of phencyclidine.

Author information

1
CNS Research, Bayer, Aprather Weg 18, D-42096, Wuppertal, Germany. rudy.schreiber.rs1@bayer-ag.de

Abstract

LY354740 ┬┐(1S,2S,5R,6S)-2-aminobicyclo[3.1.0]hexane-2, 6-dicarboxylate monohydrate┬┐, a selective group II metabotropic glutamate (mGlu) receptor agonist, was recently reported to attenuate the behavioral effects of phencyclidine (PCP) in rats. In the present study, LY354740 failed to attenuate the discriminative stimulus properties of PCP and its disruption of prepulse inhibition of the acoustic startle response, at a dose range which decreased startle responding. The suggestion that mGlu group II receptor activation induces antipsychotic effects may be premature.

PMID:
10666513
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center